Cargando…

Sprinkle formulations—A review of commercially available products

Currently, sixty-five original sprinkle drug products are available in various dosage forms including tablets, powders, granules, immediate-release capsules, extended-release capsules, delayed-release capsules, and multiparticulate drug delivery systems. By sprinkling on soft food vehicles, these pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Han Sol, Lee, Jeong-Jun, Kim, Myeong-Gyu, Kim, Ki-Taek, Cho, Cheong-Weon, Kim, Dae-Duk, Lee, Jae-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shenyang Pharmaceutical University 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327757/
https://www.ncbi.nlm.nih.gov/pubmed/32636948
http://dx.doi.org/10.1016/j.ajps.2019.05.003
_version_ 1783552608449855488
author Lee, Han Sol
Lee, Jeong-Jun
Kim, Myeong-Gyu
Kim, Ki-Taek
Cho, Cheong-Weon
Kim, Dae-Duk
Lee, Jae-Young
author_facet Lee, Han Sol
Lee, Jeong-Jun
Kim, Myeong-Gyu
Kim, Ki-Taek
Cho, Cheong-Weon
Kim, Dae-Duk
Lee, Jae-Young
author_sort Lee, Han Sol
collection PubMed
description Currently, sixty-five original sprinkle drug products are available in various dosage forms including tablets, powders, granules, immediate-release capsules, extended-release capsules, delayed-release capsules, and multiparticulate drug delivery systems. By sprinkling on soft food vehicles, these products provide dosing flexibility and convenience of administration, which potentially improve the compliance of patients with dysphagia. Due to these advantages, the growth of sprinkle products picked up since the 1990s, and several regulatory issues regarding this dosage form have been raised and documented. In this article, the types of sprinkle formulations were discussed by dividing them into seven categories, and the commercial products were summarized in terms of the drug substance, pharmaceutical excipients, storage conditions and administration methods. In addition, several US Food and Drug Administration guidelines related to the regulatory issues of sprinkle formulations were reviewed, which led to the conclusion that the future development of this promising dosage form demands integrated guidance for industry rather than scattered information in various documents.
format Online
Article
Text
id pubmed-7327757
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Shenyang Pharmaceutical University
record_format MEDLINE/PubMed
spelling pubmed-73277572020-07-06 Sprinkle formulations—A review of commercially available products Lee, Han Sol Lee, Jeong-Jun Kim, Myeong-Gyu Kim, Ki-Taek Cho, Cheong-Weon Kim, Dae-Duk Lee, Jae-Young Asian J Pharm Sci Review article Currently, sixty-five original sprinkle drug products are available in various dosage forms including tablets, powders, granules, immediate-release capsules, extended-release capsules, delayed-release capsules, and multiparticulate drug delivery systems. By sprinkling on soft food vehicles, these products provide dosing flexibility and convenience of administration, which potentially improve the compliance of patients with dysphagia. Due to these advantages, the growth of sprinkle products picked up since the 1990s, and several regulatory issues regarding this dosage form have been raised and documented. In this article, the types of sprinkle formulations were discussed by dividing them into seven categories, and the commercial products were summarized in terms of the drug substance, pharmaceutical excipients, storage conditions and administration methods. In addition, several US Food and Drug Administration guidelines related to the regulatory issues of sprinkle formulations were reviewed, which led to the conclusion that the future development of this promising dosage form demands integrated guidance for industry rather than scattered information in various documents. Shenyang Pharmaceutical University 2020-05 2019-07-08 /pmc/articles/PMC7327757/ /pubmed/32636948 http://dx.doi.org/10.1016/j.ajps.2019.05.003 Text en © 2019 Shenyang Pharmaceutical University. Published by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review article
Lee, Han Sol
Lee, Jeong-Jun
Kim, Myeong-Gyu
Kim, Ki-Taek
Cho, Cheong-Weon
Kim, Dae-Duk
Lee, Jae-Young
Sprinkle formulations—A review of commercially available products
title Sprinkle formulations—A review of commercially available products
title_full Sprinkle formulations—A review of commercially available products
title_fullStr Sprinkle formulations—A review of commercially available products
title_full_unstemmed Sprinkle formulations—A review of commercially available products
title_short Sprinkle formulations—A review of commercially available products
title_sort sprinkle formulations—a review of commercially available products
topic Review article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327757/
https://www.ncbi.nlm.nih.gov/pubmed/32636948
http://dx.doi.org/10.1016/j.ajps.2019.05.003
work_keys_str_mv AT leehansol sprinkleformulationsareviewofcommerciallyavailableproducts
AT leejeongjun sprinkleformulationsareviewofcommerciallyavailableproducts
AT kimmyeonggyu sprinkleformulationsareviewofcommerciallyavailableproducts
AT kimkitaek sprinkleformulationsareviewofcommerciallyavailableproducts
AT chocheongweon sprinkleformulationsareviewofcommerciallyavailableproducts
AT kimdaeduk sprinkleformulationsareviewofcommerciallyavailableproducts
AT leejaeyoung sprinkleformulationsareviewofcommerciallyavailableproducts